Exhibit 10.9
| 279 E. Grand Avenue South San Francisco, CA 94080 (ph) 650.566.1402 (fx) 650.566.1429 www.dicemolecules.com
|
September 24, 2021
Timothy Lu, PhD, MD
Via Email
Dear Dr. Lu:
This letter agreement amends and restates the offer letter between you and DICE Therapeutics, Inc. (the “Company”)1, dated July 23, 2020 (the “Prior Agreement”) effective [ ]2, 2021.
You will continue to work in the role of Chief Medical Officer, reporting to the Company’s Chief Executive Officer. As an exempt salaried employee, you may be expected to work additional hours as required by the nature of your work assignments.
As part of the Company’s executive team, you will have the responsibilities associated with the role of the Company’s Chief Medical Officer. You will work at our facility located at 279 E. Grand Avenue, South San Francisco, CA 94080. The Company may change your position and work location from time to time at its discretion.
1 Any reference to the Company will be understood to include any direct or indirect subsidiary of the Company that employs you, including DICE Therapeutics, Inc.
2 To be the effective date of the S-1 registration statement.
any oral or written agreement in conflict with any of the provisions of this letter or the Company’s policies. You are not to bring with you to the Company, or use or disclose to any person associated with the Company, any confidential or proprietary information belonging to any former employer or other person or entity with respect to which you owe an obligation of confidentiality under any agreement or otherwise. The Company does not need and will not use such information and we will assist you in any way possible to preserve and protect the confidentiality of proprietary information belonging to third parties. Also, we expect you to abide by any obligations to refrain from soliciting any person employed by or otherwise associated with any former employer and suggest that you refrain from having any contact with such persons until such time as any non-solicitation obligation expires.
Employment Opportunity Commission, the Department of Labor, and applicable state and local agencies); and
This letter agreement supersedes and replaces any prior understandings or agreements, whether oral, written or implied, between you and the Company regarding the matters described in this letter (other than the Severance Agreement), including, without limitation, the Prior Agreement. This letter will be governed by the laws of California, without regard to its conflict of laws provisions.
|
|
|
| Very truly yours, |
|
|
|
| DICE THERAPEUTICS, INC. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| /s/ J. Kevin Judice, Ph.D. |
|
|
|
| By: J. Kevin Judice, Ph.D. |
|
|
|
| Chief Executive Officer
|
ACCEPTED AND AGREED: |
|
|
|
|
|
|
|
|
|
/s/ Timothy Lu |
|
|
|
|
By: Timothy Lu |
|
|
|
|
|
|
|
|
|
Date: Dec 1, 2021 |
|
|
|
|